Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Epigenetics Market Research Report 2019-2025

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Epigenetics Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 DNA Methylation
      • 1.3.3 Histone Modifications
      • 1.3.4 Other Technologies
    • 1.4 Market Segment by Application
      • 1.4.1 Global Epigenetics Market Share by Application (2019-2025)
      • 1.4.2 Oncology
      • 1.4.3 Metabolic Diseases
      • 1.4.4 Developmental Biology
      • 1.4.5 Immunology
      • 1.4.6 Cardiovascular Diseases
      • 1.4.7 Other Applications
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Epigenetics Market Size
      • 2.1.1 Global Epigenetics Revenue 2014-2025
      • 2.1.2 Global Epigenetics Sales 2014-2025
    • 2.2 Epigenetics Growth Rate by Regions
      • 2.2.1 Global Epigenetics Sales by Regions 2014-2019
      • 2.2.2 Global Epigenetics Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Epigenetics Sales by Manufacturers
      • 3.1.1 Epigenetics Sales by Manufacturers 2014-2019
      • 3.1.2 Epigenetics Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Epigenetics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Epigenetics Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Epigenetics Market Concentration Ratio (CR5 and HHI)
    • 3.3 Epigenetics Price by Manufacturers
    • 3.4 Key Manufacturers Epigenetics Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Epigenetics Market
    • 3.6 Key Manufacturers Epigenetics Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 DNA Methylation Sales and Revenue (2014-2019)
      • 4.1.2 Histone Modifications Sales and Revenue (2014-2019)
      • 4.1.3 Other Technologies Sales and Revenue (2014-2019)
    • 4.2 Global Epigenetics Sales Market Share by Type
    • 4.3 Global Epigenetics Revenue Market Share by Type
    • 4.4 Epigenetics Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Epigenetics Sales by Application

    6 United States

    • 6.1 United States Epigenetics Breakdown Data by Company
    • 6.2 United States Epigenetics Breakdown Data by Type
    • 6.3 United States Epigenetics Breakdown Data by Application

    7 European Union

    • 7.1 European Union Epigenetics Breakdown Data by Company
    • 7.2 European Union Epigenetics Breakdown Data by Type
    • 7.3 European Union Epigenetics Breakdown Data by Application

    8 China

    • 8.1 China Epigenetics Breakdown Data by Company
    • 8.2 China Epigenetics Breakdown Data by Type
    • 8.3 China Epigenetics Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Epigenetics Breakdown Data by Company
    • 9.2 Rest of World Epigenetics Breakdown Data by Type
    • 9.3 Rest of World Epigenetics Breakdown Data by Application
    • 9.4 Rest of World Epigenetics Breakdown Data by Countries
      • 9.4.1 Rest of World Epigenetics Sales by Countries
      • 9.4.2 Rest of World Epigenetics Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Illumina
      • 10.1.1 Illumina Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Epigenetics
      • 10.1.4 Epigenetics Product Introduction
      • 10.1.5 Illumina Recent Development
    • 10.2 Thermo Fisher Scientific
      • 10.2.1 Thermo Fisher Scientific Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Epigenetics
      • 10.2.4 Epigenetics Product Introduction
      • 10.2.5 Thermo Fisher Scientific Recent Development
    • 10.3 Merck Millipore
      • 10.3.1 Merck Millipore Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Epigenetics
      • 10.3.4 Epigenetics Product Introduction
      • 10.3.5 Merck Millipore Recent Development
    • 10.4 Abcam
      • 10.4.1 Abcam Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Epigenetics
      • 10.4.4 Epigenetics Product Introduction
      • 10.4.5 Abcam Recent Development
    • 10.5 Active Motif
      • 10.5.1 Active Motif Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Epigenetics
      • 10.5.4 Epigenetics Product Introduction
      • 10.5.5 Active Motif Recent Development
    • 10.6 Bio-Rad
      • 10.6.1 Bio-Rad Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Epigenetics
      • 10.6.4 Epigenetics Product Introduction
      • 10.6.5 Bio-Rad Recent Development
    • 10.7 New England Biolabs
      • 10.7.1 New England Biolabs Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Epigenetics
      • 10.7.4 Epigenetics Product Introduction
      • 10.7.5 New England Biolabs Recent Development
    • 10.8 Agilent
      • 10.8.1 Agilent Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Epigenetics
      • 10.8.4 Epigenetics Product Introduction
      • 10.8.5 Agilent Recent Development
    • 10.9 Qiagen
      • 10.9.1 Qiagen Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Epigenetics
      • 10.9.4 Epigenetics Product Introduction
      • 10.9.5 Qiagen Recent Development
    • 10.10 Zymo Research
      • 10.10.1 Zymo Research Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Epigenetics
      • 10.10.4 Epigenetics Product Introduction
      • 10.10.5 Zymo Research Recent Development
    • 10.11 Perkinelmer
    • 10.12 Diagenode

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Epigenetics Sales Channels
      • 11.2.2 Epigenetics Distributors
    • 11.3 Epigenetics Customers

    12 Market Forecast

    • 12.1 Global Epigenetics Sales and Revenue Forecast 2019-2025
    • 12.2 Global Epigenetics Sales Forecast by Type
    • 12.3 Global Epigenetics Sales Forecast by Application
    • 12.4 Epigenetics Forecast by Regions
      • 12.4.1 Global Epigenetics Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Epigenetics Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Based on product, the global market for epigenetics, is segmented into enzymes, instruments and consumables, kits, reagents, and bioinformatics tools. In 2017, the kits segment accounted for the largest share of global market for epigenetics. The large share of this segment is attributed to the fact that a large number of kits are used in epigenetic techniques. The rising prevalence of a number of diseases, increasing R&D spending, and increased government funding for life science research are the other factors supporting market growth.
      Market growth can be attributed to the decreasing sequencing costs, increase in research activities, availability of funding for epigenetics research, and rising prevalence of cancer.
      In 2019, the market size of Epigenetics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of 4.8% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Epigenetics.

      This report studies the global market size of Epigenetics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Epigenetics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Illumina 
      Thermo Fisher Scientific 
      Merck Millipore 
      Abcam 
      Active Motif 
      Bio-Rad 
      New England Biolabs 
      Agilent 
      Qiagen 
      Zymo Research 
      Perkinelmer 
      Diagenode

      Market Segment by Product Type
      DNA Methylation
      Histone Modifications
      Other Technologies

      Market Segment by Application
      Oncology
      Metabolic Diseases
      Developmental Biology
      Immunology
      Cardiovascular Diseases
      Other Applications

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Epigenetics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Epigenetics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Epigenetics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now